Inflammation

May 24, 2017

Natural product-derived therapy for Inflammatory bowel disease: Genistein, isolated from Soy products, promotes NFKB-p50/p65 dimer formation, induces inflammatory gene expression downstream of RelA/p65, inhibits colonic pathogenesis, and stalls the progression of inflammatory bowel disease and colitis via down regulation of its target gene, 24/May/2017, 7.36 am

Introduction: What they say: A study from the Institute for Molecular Medicine, University Medical Center of the Johannes Gutenberg, University of Mainz, Obere Zahlbarer Str, Mainz, […]
February 8, 2015

Molecular therapy for Inflammatory Bowel disease (IBD): E2F3 preserves the functions of Beclin 1 and ATG5 and decreases tissue injury in inflammatory bowel disease (IBD) via down regulation of its target gene, 08/February/2015, 23.32

A study from Department of Medicine, University of Chicago, Chicago, Illinois, USA shows that “Cytosolic HMGB1 controls the cellular autophagy/apoptosis checkpoint during inflammation.” This study was published in the […]
July 18, 2014

Therapeutic insights into improving intestinal immunity: Tumor suppressor p53 inhibits the progression of inflammatory bowel disease (IBD) and colitis-associated colorectal cancer via up regulation of its target gene , 18/July/2014, 8.55 am

Idea Proposed/Formulated by: Dr L Boominathan PhD Web: http://genomediscovery.org Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/ Citation: Boominathan,Therapeutic insights into improving intestinal immunity: Tumor suppressor p53 inhibits the progression of inflammatory bowel disease (IBD) […]